×
About 632 results

ALLMedicine™ Diuretics Center

Research & Reviews  211 results

Development and validation of a fast ultra high-performance liquid chromatography tande...
https://doi.org/10.1002/dta.3055
Drug Testing and Analysis; Lo Faro AF, Tini A et. al.

Apr 28th, 2021 - A new, rapid, sensitive and comprehensive ultra-high-performance liquid chromatographic-mass spectrometry (UHPLC-MS/MS) method for quantifying diuretics (acetazolamide, brinzolamide, dorzolamide and their metabolites) in human urine and hair was d...

Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort stu...
https://doi.org/10.1111/bjd.19880
The British Journal of Dermatology; Schneider R, Reinau D et. al.

Feb 20th, 2021 - Case-control studies report a dose-dependent increased risk of skin cancer in users of hydrochlorothiazide (HCTZ) vs. nonusers. The degree to which other thiazides and thiazide-like diuretics (TZs) are associated with skin cancer is less certain. ...

Loop Diuretics: Clinical Application Information for Nephrology Nurses and Practitioners.
https://www.ncbi.nlm.nih.gov/pubmed/33377756
Nephrology Nursing Journal : Journal of the American Neph... Nguyen T

Dec 30th, 2020 - Loop diuretic medications work by inhibiting sodium reabsorption in the renal tubules. The net effect is increasing in urinary sodium and water excretion. Loop diuretics are routinely used for many clinical indications, and nephrology practitioner...

Intensification of pharmacological decongestion but not the actual daily loop diuretic ...
https://doi.org/10.1007/s00392-020-01779-7
Clinical Research in Cardiology : Official Journal of The... Simonavičius J, Maeder MT et. al.

Nov 20th, 2020 - Both loop diuretics (LDs) and congestion have been related to worse heart failure (HF) outcome. The relationship between the cause and effect is unknown. The aim of this study was to investigate the interaction between congestion, diuretic use and...

Outcomes of diuretics in rheumatic heart disease with compensated chronic heart failure...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754903
ESC Heart Failure; Liu C, Lai Y et. al.

Sep 18th, 2020 - The purpose of this retrospective propensity score-matched study was to evaluate the superiority of different application approaches [continuous diuretics use (CDU) vs. intermittent diuretics use (IDU)] and types [loop diuretics (LDs) vs. thiazide...

see more →

Drugs  83 results see all →

Clinicaltrials.gov  321 results

Ramipril - ramipril capsule-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20676a93-af57-40ff-827d-f80892af7517

May 2nd, 2021 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Development and validation of a fast ultra high-performance liquid chromatography tande...
https://doi.org/10.1002/dta.3055
Drug Testing and Analysis; Lo Faro AF, Tini A et. al.

Apr 28th, 2021 - A new, rapid, sensitive and comprehensive ultra-high-performance liquid chromatographic-mass spectrometry (UHPLC-MS/MS) method for quantifying diuretics (acetazolamide, brinzolamide, dorzolamide and their metabolites) in human urine and hair was d...

Ramipril - ramipril capsule-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1797d9e-148c-423d-a096-ee21efad05f2

Apr 14th, 2021 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Ramipril - ramipril capsule-Lake Erie Medical DBA Quality Care Products LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7badfa7-e27f-4cfa-bc1b-e9eecf5f0248

Apr 14th, 2021 - Ramipril capsules are an angiotensin converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes an...

Carvedilol phosphate - carvedilol phosphate capsule, extended release-Golden State Medical Supply, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=669ec7f8-f27d-4048-a784-00ca903cc658

Apr 1st, 2021 - Carvedilol phosphate extended-release capsules are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: hypertension ( 1.3) Carvedilol phosphate extended-release capsules are indicated for the management of essential hypertensi...

see more →

News  15 results

Loop Diuretics: Getting the Dose Right
https://www.medscape.com/viewarticle/915184

Jul 9th, 2019 - Loop diuretics are widely used in the management of edema and heart failure. They are also widely misunderstood. The reason is this: Loop diuretics are often prescribed in a dose-dependent strategy. Looking for gentle diuresis? Prescribe a low dos...

Quarter of Seniors Off HTN Meds; Early Birth or Menopause Risky; Drink Daily for Afib?
https://www.medpagetoday.com/cardiology/prevention/60267

Sep 15th, 2016 - The CDC reported that 26% of Medicare Part D beneficiaries on antihypertension medication didn't adhere to it, corresponding to 4.9 million Americans. The report in Morbidity and Mortality Weekly Report showed higher nonadherence rates with diuret...

Diabetes Risk Grows as Heart Failure Worsens
https://www.medpagetoday.com/cardiology/chf/45914

May 21st, 2014 - Worsening heart failure severity -- indicated by increasing doses of loop diuretics -- was associated in a dose-dependent manner with rising risks of developing diabetes, a Danish study showed. The risk of developing diabetes was about three times...

Increased Gout Risk With Diuretic Use Confirmed
https://www.medpagetoday.com/rheumatology/generalrheumatology/30513

Jan 5th, 2012 - Action Points Use of diuretics has been shown to be associated with gout, but many of the studies were in patients being treated for hypertension and it is conceivable that the underlying hypertension may itself have contributed to the association...

Hypertension Highlights: Does It All Begin and End With ALLHAT?
https://www.medscape.com/viewarticle/718411

Mar 17th, 2010 - This Hypertension Highlights newsletter kicked off 7 years ago in December 2002 with the first results of what is still the largest hypertension trial ever conducted. I'm referring, of course, to the Antihypertensive and Lipid-Lowering Treatment t...

see more →

Patient Education  2 results see all →